Validation of a clinical and genetic model for predicting severe COVID-19
View ORCID ProfileGillian S. Dite, View ORCID ProfileNicholas M. Murphy, View ORCID ProfileErika Spaeth, View ORCID ProfileRichard Allman, Lifelines Corona Research Initiative
doi: https://doi.org/10.1101/2022.01.14.22269270
Gillian S. Dite
1Genetic Technologies Limited, Fitzroy, Victoria, Australia
Nicholas M. Murphy
1Genetic Technologies Limited, Fitzroy, Victoria, Australia
Erika Spaeth
2Phenogen Sciences Inc, Charlotte, North Carolina, United States of America
Richard Allman
1Genetic Technologies Limited, Fitzroy, Victoria, Australia
Article usage
Posted January 15, 2022.
Validation of a clinical and genetic model for predicting severe COVID-19
Gillian S. Dite, Nicholas M. Murphy, Erika Spaeth, Richard Allman, Lifelines Corona Research Initiative
medRxiv 2022.01.14.22269270; doi: https://doi.org/10.1101/2022.01.14.22269270
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)